Johnson & Johnson is working on a drug to treat depression and insomnia. In a Phase III trial, participants who took the drug experienced meaningful improvement in both sleep and depressive symptoms, with an antidepressant effect that seemed to be independent of the participants getting better sleep. The drug is part of a new class…